Bacterial products increase expression of the human cathelicidin hCAP-18/LL-37 in cultured human sinus epithelial cells

被引:53
|
作者
Nell, MJ
Tjabringa, GS
Vonk, MJ
Hiemstra, PS
Grote, JJ
机构
[1] Leiden Univ, Med Ctr, Dept Otolaryngol, NL-2300 RC Leiden, Netherlands
[2] OctoPlus Technol, Leiden, Netherlands
[3] Leiden Univ, Ctr Med, Dept Pulm, Leiden, Netherlands
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2004年 / 42卷 / 02期
关键词
respiratory epithelium; antimicrobial peptides; mucin; lipopolysaccharide; lipoteichoic acid; innate immunity;
D O I
10.1016/j.femsim.2004.05.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The respiratory epithelium plays a major role in the primary defense of the airways against infection. It has been demonstrated that bacterial products are involved in the induction of inflammatory reactions of the upper airways. Little is known about the effects of bacterial products on expression of the antimicrobial peptide hCAP-18/LL-37, the only human cathelicidin identified so far. The aim of this study was to investigate the effects of bacterial products from both gram-positive and gram-negative bacteria on the expression of hCAP-18/LL-37 by sinus epithelial cells using an air-exposed tissue culture model. Lipopolysaccharide and lipoteichoic acid both increased hCAP-18/LL-37 expression in cultured sinus epithelium as assessed by immunohistochemistry, where maximal stimulation occurred at 100 ng ml(-1) lipopolysaccharide or 10 mug ml(-1) lipoteichoic acid. The stimulatory effect of lipopolysaccharide and lipoteichoic acid was not restricted to expression of hCAP-18/LL-37, since also mucin expression and IL-8 release from cultured sinus epithelium cells were increased by lipopolysaccharide and lipoteichoic acid. This suggests that bacterial products may stimulate innate immunity in the upper airways. (C) 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 50 条
  • [1] Pulmonary defense and the human cathelicidin hCAP-18/LL-37
    Fahy, RJ
    Wewers, MA
    IMMUNOLOGIC RESEARCH, 2005, 31 (02) : 75 - 89
  • [2] Pulmonary defense and the human cathelicidin hCAP-18/LL-37
    R. J. Fahy
    M. D. Wewers
    Immunologic Research, 2005, 31 : 75 - 89
  • [3] Expression of LL-37/hCAP-18 gene in human leukemia cells
    Yang, YH
    Zheng, GG
    Li, G
    Zhang, B
    Song, YH
    Wu, KF
    LEUKEMIA RESEARCH, 2003, 27 (10) : 947 - 950
  • [4] Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors
    Benachour, H.
    Zaiou, M.
    Samara, A.
    Herbeth, B.
    Pfister, M.
    Lambert, D.
    Siest, G.
    Visvikis-Siest, S.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (10) : 720 - 728
  • [5] Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
    Schauber, Juergen
    Rieger, Daniel
    Weiler, Frank
    Wehkamp, Jan
    Eck, Matthias
    Fellermann, Klaus
    Scheppach, Wolfgang
    Gallo, Richard L.
    Stange, Eduard F.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (06) : 615 - 621
  • [6] The human cathelicidin hCAP18/LL-37: A multifunctional peptide involved in mycobacterial infections
    Mendez-Samperio, Patricia
    PEPTIDES, 2010, 31 (09) : 1791 - 1798
  • [7] Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence
    Zaiou, M
    Nizet, V
    Gallo, RL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (05) : 810 - 816
  • [8] Vitamin D3 analog maxacalcitol (OCT) induces hCAP-18/LL-37 production in human oral epithelial cells
    Tada, Hiroyuki
    Shimizu, Takamitsu
    Nagaoka, Isao
    Takada, Haruhiko
    BIOMEDICAL RESEARCH-TOKYO, 2016, 37 (03): : 199 - 205
  • [9] Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
    Podaza, Enrique
    Palacios, Florencia
    Croci, Diego O.
    Risnik, Denise
    Yan, Xiao J.
    Almejun, Maria Belen
    Colado, Ana
    Elias, Esteban E.
    Borge, Mercedes
    Morande, Pablo E.
    Bezares, Raimundo
    Fernandez-Grecco, Horacio
    Rabinovich, Gabriel A.
    Gamberale, Romina
    Chiorazzi, Nicholas
    Giordano, Mirta
    HAEMATOLOGICA, 2020, 105 (09) : E465 - E469
  • [10] Statins influence epithelial expression of the anti-microbial peptide LL-37/hCAP-18 independently of the mevalonate pathway
    Luthje, P.
    Walker, S.
    Kamolvit, W.
    Mohanty, S.
    Putsep, K.
    Brauner, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 195 (02) : 265 - 276